Vivos Inc. (RDGL)
OTCMKTS · Delayed Price · Currency is USD
0.0580
-0.0014 (-2.32%)
Jul 31, 2026, 1:59 PM EST
Vivos Market Cap
Vivos has a market cap or net worth of $29.33 million as of July 31, 2026. Its market cap has decreased by -51.26% in one year.
Market Cap
29.33M
Enterprise Value
36.26M
Revenue
77.70K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
ChartMarket Cap Chart
Since September 1, 1998, Vivos's market cap has increased from 12.08M to 29.33M, an increase of 142.71%. That is a compound annual growth rate of 3.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 29.33M | -6.48% |
| Dec 31, 2025 | 31.36M | -37.86% |
| Dec 31, 2024 | 50.47M | 81.66% |
| Dec 29, 2023 | 27.78M | 73.14% |
| Dec 30, 2022 | 16.05M | -44.73% |
| Dec 31, 2021 | 29.03M | -5.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zomedica | 86.24M |
| RetinalGenix Technologies | 75.02M |
| Positron | 54.85M |
| Tian'an Technology Group | 45.52M |
| Guided Therapeutics | 28.96M |
| Family Office of America | 27.32M |
| PetVivo Holdings | 24.06M |
| CS Diagnostics | 17.50M |